Günther Staffler
Chief Tech/Sci/R&D Officer at AFFiRiS AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Oliver Siegel | M | 58 |
AFFiRiS AG
 AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | 10 years |
| Michael Motschmann | M | 67 |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
| Thomas Kapsner | M | - |
Biovertis AG
 Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | 18 years |
| Christoph Huber | M | 80 |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | 9 years |
| Gregory Lynn | M | 59 |
University of Vienna
| 24 years |
| Claudia Juno | F | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | 16 years |
| Noel Barrett | M | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
| Marie Le Bras | F | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Georg C. Reitboeck | M | - |
University of Vienna
| 5 years |
| Alexander Ullrich von Gabain | M | 73 |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | - |
| Erich Felber | M | - |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | - |
| Elmar Platzgummer | M | - |
University of Vienna
| 3 years |
| Thomas Gramatté | M | - |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | - |
| Arne von Bonin | M | 59 |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
| Wolfgang Baier | M | 50 |
University of Vienna
| 3 years |
| Henriette Mark | F | 67 |
University of Vienna
| 2 years |
| Hannes Moesenbacher | M | 52 |
University of Vienna
| 3 years |
| Vera Bürger | F | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
| Stefan Weinhofer | M | 49 |
University of Vienna
| 7 years |
| Wolfgang Koberl | M | - |
University of Vienna
| 4 years |
| Thomas Muchar | M | 50 |
University of Vienna
| 1 years |
| Thomas Schmid | M | 48 |
University of Vienna
| 3 years |
| Hanna Bomba | F | 46 |
University of Vienna
| 6 years |
| Michael Höllerer | M | 46 |
University of Vienna
| 3 years |
| Lucas Prunbauer | M | 41 |
University of Vienna
| 7 years |
| Christina Schmidbauer | M | 49 |
University of Vienna
| 1 years |
| Dávid Maász | M | 48 |
University of Vienna
| 4 years |
| Veronika Janyrova | F | - |
University of Vienna
| 5 years |
| Bernhard Tollay | M | - |
University of Vienna
| 4 years |
| Cornelia Kutzer | F | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
| Dorothea Sztopko | F | - |
University of Vienna
| 6 years |
| Daniel Alge | M | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
| Maximilian Pasquali | M | - |
University of Vienna
| 2 years |
| Sabine Mlnarsky-Bstandig | F | 49 |
University of Vienna
| 3 years |
| Dietmar Czernich | M | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
| Gertraud Unterrainer | M | - |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | - |
| Stefan Riedler | M | 53 |
University of Vienna
| 3 years |
| Judit Ágnes Havasi | M | 49 |
University of Vienna
| 3 years |
| Markus Mandler | M | - |
University of Vienna
| 3 years |
| Markus Braun | M | 54 |
University of Vienna
| 4 years |
| Greg F. Walker | M | - |
University of Vienna
| 2 years |
| Elisabeth Staudinger-Leibrecht | F | - |
University of Vienna
| 1 years |
| Georg Blumauer | M | 50 |
University of Vienna
| 3 years |
| Veronika Haslinger | F | 52 |
University of Vienna
| 6 years |
| Albert Dürr | M | 48 |
University of Vienna
| 3 years |
| Simon Weinberger | M | - |
University of Vienna
| 4 years |
| Elisabeth Wagerer | F | 43 |
University of Vienna
| 11 years |
| Ali Alloueche | M | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | - |
| Karin Schuster | F | - |
University of Vienna
| 4 years |
| Monika Wildner | M | 53 |
University of Vienna
| 4 years |
| Christian Mandl | M | - |
University of Vienna
| 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Austria | 51 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Günther Staffler
- Personal Network
